INS and metabolic dysfunction-associated steatotic liver disease: The beneficial effects of AMPK activation, including improved insulin sensitivity [93,94,95], enhanced mitochondrial function [96], and reduced lipid accumulation [97,98,99] in the liver, contribute to improved liver function and reduced risk of MASLD.